在青少年使用自动化胰岛素输送系统对分级运动测试的血糖反应
Emilie Bundgaard Lindkvist1,2, Olivia Mary McCarthy1,3, Sandra Tawfik1
1Steno Diabetes Center Copenhagen, Clinical Translational Research, Diabetes Technology Research, Herlev, Denmark.
Diabetes technology & therapeutics
|November 7, 2025
概括
使用自动化胰岛素输送系统的1型糖尿病青少年可以安全地进行分级运动测试. 他们的葡萄糖水平在运动期间和之后保持稳定,显示最小的低血糖.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 儿童糖尿病管理 儿童糖尿病管理
背景情况:
- 1型糖尿病 (T1D) 的管理需要仔细监测血糖水平,特别是在体力活动期间.
- 自动化胰岛素输送 (AID) 系统为T1D患者提供先进的血糖控制.
- 了解使用AID的青少年的运动反应对于安全有效的管理至关重要.
研究的目的:
- 在分级运动测试 (GXT) 中使用AID系统评估T1D青少年的血糖反应.
- 在这个人群中评估GXT期间和之后葡萄糖水平的安全性和稳定性.
主要方法:
- 使用AID系统的24名患有T1D的青少年参加了自行车人体表GXT,直到疲.
- 在测试期间测量了血葡萄糖和乳酸盐水平.
- 持续血糖监测 (CGM) 数据是在运动后收集的,用于24小时的监测.
主要成果:
- 在整个GXT期间,血葡萄糖水平保持稳定,没有显著的整体变化 (-0.26 mmol/L).
- 在GXT期间没有发生过低血糖事件.
- 运动后的传感器葡萄糖水平保持在目标范围内,只有轻微的,不经常出现的轻微低血糖症.
结论:
- 分级炼测试对AID系统管理的T1D青少年来说是血糖安全的.
- 在这个群体中,AID系统在艰苦的体力活动期间和之后有效地保持血糖控制.
- 这一发现支持将定期炼纳入使用AID的T1D青少年的生活方式.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
665
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
665
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Hypoglycemia and Glucagon
787
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
787
Insulin Formulations: Types and Delivery
632
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
632
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Hormones Regulating Blood Glucose
6.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.4K


